Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-21

FDA Approved: CARBIDOPA-LEVODOPA — Original Application (Advagen Pharma Ltd.,)

View source ↗

Summary

The FDA approved Advagen Pharma's original application for a generic carbidopa-levodopa product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • carbidopa-levodopa (carbidopa-levodopa)

Snippet

ORIG AP for CARBIDOPA-LEVODOPA (CARBIDOPA AND LEVODOPA)